GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Antibody Patient Onset (days) Symptom ▲ GlyTouCan ID Arbitrary Fluorescence Units (AFU)
IgA
Patient 2
24
mild
384
IgA
Patient 2
24
mild
416
IgA
Patient 2
24
mild
2058
IgA
Patient 2
24
mild
311
IgA
Patient 2
24
mild
593
IgA
Patient 2
24
mild
1074
IgA
Patient 2
24
mild
464
IgA
Patient 2
24
mild
407
IgA
Patient 2
24
mild
356
IgA
Patient 2
24
mild
1457
Displaying entries 201 - 210 of 4050 in total

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01